Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | -0.32% | 333.78 | 0.0% | $4532.00m | |
| NVAX | Novavax, Inc. | -0.51% | 165.40 | 79.4% | $744.04m | |
| BNTX | BioNTech SE | 1.71% | 265.57 | 0.0% | $716.89m | |
| AMGN | Amgen, Inc. | 1.16% | 205.48 | 1.4% | $544.47m | |
| SNSS | Sunesis Pharmaceuticals, Inc. | 0.64% | 6.30 | 0.7% | $440.39m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.96% | 554.15 | 2.7% | $427.79m | |
| GILD | Gilead Sciences, Inc. | 1.12% | 66.64 | 1.0% | $412.41m | |
| CCXI | ChemoCentryx, Inc. | 5.40% | 34.18 | 2.9% | $405.99m | |
| ILMN | Illumina, Inc. | 0.15% | 411.13 | 3.3% | $375.21m | |
| XLRN | Acceleron Pharma, Inc. | 0.23% | 173.39 | 5.3% | $363.27m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 1.98% | 184.38 | 1.9% | $263.38m | |
| BIIB | Biogen, Inc. | 0.40% | 270.81 | 1.7% | $234.60m | |
| OCGN | Ocugen, Inc. | 2.00% | 8.43 | 0.0% | $182.22m | |
| XENE | Xenon Pharmaceuticals, Inc. | 1.03% | 31.04 | 0.4% | $173.54m | |
| CRSP | CRISPR Therapeutics AG | 4.41% | 100.45 | 0.6% | $161.01m |
Company Profile
BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.